Key Health & Wellness statistics in the United States, 2026

How does health & wellness in the United States compare? Sector benchmarks

One benchmark figure per monthly report, newest first.

What are the key health & wellness figures in the United States?

August 2026

• Over 100 million Americans carry medical debt averaging $2,000-$3,100, with aggregate debt estimated at $195-220 billion, directly fueling a shift toward cash-pay preventative wellness spending. — Audience Profiles
• Millennials carry the highest medical debt burden (30% of the cohort) yet account for roughly 41% of total wellness category spending, making them the highest-value target for debt-avoidance messaging. — Audience Profiles
• The wearables market has reached approximately $109 billion with 32% consumer penetration, while longevity clinics have grown to a $6.02 billion market expanding at a 12.2% CAGR as consumers bypass insurance-dependent care. — Audience Profiles
• Debt-avoidant consumers show high willingness to adopt untested modalities when peer-validated — 87% will trial a product with peer endorsement — but demand transparency, with 82% requiring clinical or efficacy evidence before sustained adoption. — Audience Profiles
• Midwest adoption of preventative wellness lags other U.S. regions (4.8% CAGR vs. 5.5-6.9% nationally), with sharp urban-rural divergence — states like South Dakota show the region's highest medical debt prevalence (17.7% of adults) — creating both a constraint and a underserved opportunity for targeted activation. — Audience Profiles
• Sleep tech and AI recovery platforms are growing at approximately 17-18% CAGR, with the segment sized at roughly $29-35 billion in 2026 and projected to reach $57 billion-plus by 2030. — Competitive Benchmark
• Subscription retention is now the sharpest competitive divide: Whoop reports approximately 90% annual retention versus roughly 8.5% Day-30 retention for meditation apps like Calm and Headspace. — Competitive Benchmark
• Valuations concentrate around a handful of leaders — Whoop ($10.1B), Oura ($11B), Eight Sleep ($1.5B) — while legacy meditation-app players face subscriber declines and workforce reductions. — Competitive Benchmark
• The top 5 wearable and recovery-tech players hold an estimated 62% combined market share, with Apple's ecosystem gravity and Samsung's Galaxy Ring representing the largest disruptive threats to independents. — Competitive Benchmark
• Market Maturity with Digital Acceleration: US wellness economy has decelerated to 5-6% CAGR (from 7.9% prior) reflecting maturity, yet digital health, wearables, and AI-driven personalization accelerate at 13-27.8% CAGR. The $2.1 trillion market ($1.61T direct wellness, $2.7T by 2035) remains recession-resistant, with consumers planning +13% spending increases in 2026 despite broader economic uncertainty. — Market Analysis
• Investor-Driven Consolidation Reshaping Industry Structure: Q1 2026 witnessed 47 disclosed M&A transactions ($3.5B value) plus 40 undisclosed deals; IPO resurgence (Hinge Health, Omada Health 2025; Oura confidential filing $11B) signals investor appetite. $2.5 trillion PE dry powder (global) and $1 trillion US-focused capital entering 2026 driving consolidation toward investor-controlled management structures. Revenue scale ($500M+) becoming prerequisite for capital market access and strategic debt financing. — Market Analysis
• Mental Health Technology as Highest-Velocity Growth Engine: Mental health tech growing 20.25% CAGR ($8.97B 2026 → $47.13B 2035); digital mental health market concentrating 50% of mega-round capital (H1 2026). Combined with digital therapeutics (38.7% annual growth) and personalized medicine ($1.398T by 2035), these segments represent $50B+ addressable opportunity attracting concentrated VC/PE investment. 62% of startups focusing on single therapeutic area signals winner-take-most dynamics. — Market Analysis
• Regulatory Bifurcation Creating Competitive Moat for Capitalized Players: FDA January 2026 General Wellness Guidance expands digital health opportunity, but FTC Healthcare Task Force (March 2026) and state-level enforcement intensify oversight. Small brands face $2K-$12K annual compliance costs; Dietary Supplement Listing Act reintroduction (H.R. 8370) would multiply costs. Regulatory complexity advantages capital-backed platforms affording compliance infrastructure over independents — structural barrier to entry becoming more pronounced. — Market Analysis
• Geographic Concentration and Demographic Reallocation Driving Channel Shift: Coastal metros (California, New York, Boston, San Francisco) concentrate 60%+ commercial wellness activity and innovation funding; rural regions face 20% hospital closure risk and 32% mortality premium vs. national average. E-commerce penetration (35-62% by segment) and omnichannel integration (mandatory for brand survival) shifting competitive advantage toward data infrastructure and last-mile execution over physical presence. Gen Z/millennials' 41% spending share (vs. 36% population) indicates sustained generational demand reallocation toward digital-first, personalized wellness solutions. — Market Analysis
• The global adaptogen market reached USD 11.92 billion in 2025 and is projected to hit USD 22.46 billion by 2034 (7.3% CAGR), with ashwagandha holding roughly 28% category share while Lion's Mane mushroom grows at 11.4% CAGR and shows 2x higher consumer preference momentum. — Social Listening
• Pricing-skepticism mentions surged 111% year-over-year (from 18% to 38% of discourse) as 37% of consumers cite rising prices as a primary concern, even as overall search and press interest in functional nutrition rose 45% and 100+ articles over six months. — Social Listening
• A 31-point perception gap exists between industry marketing claims and consumer expectations for scientific evidence, with trust index at 72/100, quality perception at 68/100, and value-for-money declining to 61/100 amid inflation pressure. — Social Listening
• TikTok dominates functional nutrition discourse with a 4.2% engagement rate and 146% year-over-year view growth, far outpacing Facebook (0.18%), while YouTube sustains authority-building long-form content with 77% retention. — Social Listening
• The Southeast U.S. market shows a 10-point urban-rural sentiment gap, with Atlanta (72/100) and Miami (70/100) leading premium adoption versus rural markets (62/100) that remain value-focused, as the region grows at 6.2% CAGR, the second-highest in the nation. — Social Listening
• Telehealth represents 25-30% of all U.S. medical visits in 2026, with the market valued at $36.1 billion and subscription-based platforms scaling faster than episodic-care competitors. — Trend Analysis
• Subscription telehealth and direct primary care models achieve 65-85% patient retention versus roughly 20-30% for traditional episodic care, with top performers reaching 6:1 LTV-to-CAC ratios against a 3:1 industry benchmark. — Trend Analysis
• AI adoption has reached 81% among physicians and 75% among health systems, with over 1,000 FDA-cleared AI tools now integrated into diagnostic and clinical workflows, accelerating at a 37% CAGR through 2030. — Trend Analysis
• Digital health investment totaled $7.4 billion in H1 2026, with capital increasingly concentrated in recurring-revenue subscription platforms and mental health telehealth commanding over $1 billion in funding. — Trend Analysis
• The industry faces a critical workforce constraint—a projected 141,160 physician shortage by 2038 and over 1 million nurse retirements by 2030—even as 81% of healthcare executives increase sustainability and ESG investment. — Trend Analysis

July 2026

• Rural telehealth adoption has stabilized at 21.8% post-pandemic (4x pre-pandemic baseline), but 22% of rural Midwest residents still lack home internet, creating a split market where digital-only outreach misses the most cost-constrained and vulnerable wellness consumers. — Audience Profiles
• Public health funding cuts ($344B in Medicaid over 10 years under the OBBA) are pushing 1.5M+ rural beneficiaries out of safety-net care and into self-directed wellness channels — generating structurally elevated demand for affordable, accessible wellness alternatives in the Midwest. — Audience Profiles
• The Midwest is the only U.S. Census region where obesity rates did not decline in 2024, reaching 46.3%, while 44% of all U.S. adults report difficulty affording healthcare — making the region's chronic disease burden both the largest wellness need and the most significant barrier to consistent engagement. — Audience Profiles
• Community-anchored activation dramatically outperforms digital-first outreach: telehealth willingness rises 13 percentage points when provider-recommended (59.7% to 67.5%), and CHW-led programs consistently achieve 80%+ engagement rates in rural Midwest populations versus under 20% for direct digital outreach alone. — Audience Profiles
• Mobile health clinics return $18 per $1 invested and serve over 10 million visits annually across 3,600+ U.S. clinics; the $50B Rural Health Transformation Program (RHTP, signed July 2025) creates a 2025–2030 policy activation window for wellness operators to partner with state-funded rural health infrastructure. — Audience Profiles
• Eli Lilly overtook Novo Nordisk to hold 58–60% of U.S. GLP-1 prescription share in Q1 2026, driven by tirzepatide's superior efficacy (20.9% body weight reduction vs. 14.9% for semaglutide in head-to-head trials) and a $149/month oral entry point via Foundayo that drew two-thirds of users who had never taken any GLP-1 drug. — Competitive Benchmark
• The FDA's February 6, 2026 enforcement action effectively eliminated the compounding pharmacy channel that served approximately 1.5 million Americans at $99–$300/month, redirecting that demand to branded products and conferring an overnight competitive advantage on compliant manufacturers and their authorized dispensing networks. — Competitive Benchmark
• Supply chain investment has become the primary long-term competitive moat: Novo Nordisk's $11 billion Catalent acquisition secured 100–150 million annual vial capacity, while Eli Lilly committed $18 billion in U.S. manufacturing facilities — collectively ensuring that the next shortage-driven competitive opening will favor these two incumbents. — Competitive Benchmark
• California eliminated Medi-Cal GLP-1 obesity coverage on January 1, 2026, while only 19% of large U.S. employers cover GLP-1s for weight loss and prior authorization burden rose from less than 25% to 83% across Medicare Part D plans — creating an access crisis that longevity clinics and direct-to-patient platforms are commercially exploiting. — Competitive Benchmark
• Next-generation GLP-1 drugs (retatrutide with 28.7% weight loss, CagriSema at 22.7%, Amgen's once-monthly MariTide) are forecast to enter the market 2028–2030, with analysts projecting the global GLP-1 market to reach $150–200 billion by 2035, suggesting the current competitive structure has 3–4 years of relative stability before a new disruption wave. — Competitive Benchmark
• Employer-sponsored health insurance costs reached $18,500 per employee in 2026 (Aon projects 9.5% increase — the highest in 15 years), making corporate wellness investment a direct financial hedge against claims cost escalation. — Market Analysis
• Mental health is the #1 corporate wellness investment priority for the sixth consecutive year: 86% of brokers report clients increasing mental health budgets, and digital EAP platforms achieve 10x higher utilization rates (15–30%) versus traditional programs (2–5%). — Market Analysis
• Chronic disease management delivers the industry's highest ROI — 3.5 to 7 times investment — as 61% of employees with chronic conditions account for 92% of employer healthcare costs; on-site clinics generate 25% cost-of-care savings with an average $2,014 per-member-per-year reduction. — Market Analysis
• AI integration is accelerating rapidly: 72% of employers plan to embed AI into wellness programs within two years, while $14.2 billion in US digital health venture capital was deployed in 2025 (+35% YoY), with AI-enabled solutions capturing 62% of all H1 2025 funding. — Market Analysis
• Point solution fatigue is the industry's defining structural weakness: employers manage an average of 22 fragmented wellness point solutions, and 84% of benefits consultants report active client demand for integrated platform consolidation — projected to lift integrated adoption from 36% to 54% of large employers by 2027. — Market Analysis
• Men's preventive screening conversation volume surged 65-85% in June-July 2026 driven by federal policy momentum (H.R. 7602, state cost-elimination legislation) and municipal proclamations, shifting prevention from personal wellness choice to systemic affordability issue. — Social Listening
• Healthcare affordability emerged as dominant discourse topic simultaneously, with 94% of healthcare leaders declaring the system unsustainable and 49% of Americans unable to afford needed care (five-year low), creating 'Preventive Care Affordability Paradox' undermining access. — Social Listening
• Mental health crisis narratives dominate with 4x male-to-female suicide rate differential, 340% YoY conversation growth, and 15% of men reporting zero close friends (5x increase since 1990), while toxic wellness content algorithmically funnels vulnerable males toward radicalization. — Social Listening
• Misinformation ecosystem dominance (87-90% non-physician content on TikTok/Instagram vs. 10-13% credible physician voices) creates accuracy deficits significant enough to undermine public trust; credible voice amplification represents highest-ROI content strategy. — Social Listening
• Geographic disparities show Southeast US with most negative sentiment and poorest outcomes (Mississippi sentiment index 22/100; Black male mortality 2x; rural broadband access 30th percentile); hyperlocal community-embedded strategies required for regional equity, not national campaigns. — Social Listening
• FDA's January 6, 2026 General Wellness Policy eliminated premarket clearance requirements for noninvasive physiologic wearables, triggering a 365% YoY surge in wearable-focused VC to $286M in early 2026 and collapsing the time-to-market for blood pressure, glucose, and HRV devices from 6–12 months to near-zero. — Trend Analysis
• Digital health VC reached $7.4B in H1 2026 (up 16% vs. H1 2025), with WHOOP raising $575M at a $10.1B valuation in March 2026 — backed by Abbott and Mayo Clinic — and Oura projecting $1.5B+ in 2026 revenue at an $11B valuation, as investors concentrate capital at the FDA-derisked wellness-clinical boundary. — Trend Analysis
• Sixty percent of US adults now own a wearable device (up 33 percentage points since 2015), health and wellness is the only consumer category with net-positive spending intent in 2026, and Gen Z and Millennials account for 41% of total wellness spend despite representing only 36% of the adult population. — Trend Analysis
• The US wearable healthcare market is growing at 14.2% CAGR and is projected to reach $48.9B by 2033 (from $19.4B in 2026), with the blood pressure wearable sub-segment alone growing at 18.2% CAGR — the fastest category in digital health — following the FDA's 2026 guidance. — Trend Analysis
• Regulatory compliance costs have shifted but not disappeared: the WHOOP case confirms that a single 'medical-grade' phrase in app copy or packaging can convert a wellness product into a regulated medical device, while FTC penalties of up to $53K per occurrence and three new state biometric privacy laws effective January 2026 create a multi-front enforcement exposure that claims-unprepared manufacturers will face at critical launch moments. — Trend Analysis

June 2026

• Gen Z and millennial consumers drive 41% of total U.S. wellness spend while representing only 36% of the adult population, with wearable technology adoption reaching 76% among Gen Z versus 36% among Boomers — a 40-point generational gap. — Audience Profiles
• The 'Maximalist Optimizer' segment (approximately 25% of wellness consumers) accounts for over 40% of category expenditure, with annual per-capita spending exceeding $6,000 and a 16.2% CAGR in personalized and preventive health services. — Audience Profiles
• Social media and influencer marketing have become the dominant discovery channel for wellness brands among younger consumers: 71% of Gen Z and millennials have purchased a wellness product after influencer exposure, with micro-influencers delivering 20:1 ROI versus 6:1 for celebrity partnerships. — Audience Profiles
• Mental health represents the fastest-growing wellness sub-category, with a $112 billion market expanding at 3.6% CAGR through 2035 and Gen Z telehealth adoption rates (22%) running four times higher than Boomers (5%). — Audience Profiles
• GLP-1 medication users and men's wellness consumers constitute the two highest-velocity emerging audiences, with the GLP-1 adjacent market projected to exceed $100 billion by 2030 and men's personal wellness growing at 12% CAGR through 2030. — Audience Profiles
• Apple's wearables segment declined 7% YoY in FY2024 to $37B as Huawei surpassed it for the global #1 smartwatch position in Q1 2025, marking the first leadership change in the category in a decade and signaling accelerating commoditization pressure on premium hardware. — Competitive Benchmark
• Oura Ring achieved $1B in revenue in 2025—doubling year-over-year—while securing a $11B valuation at Series E, making it the fastest-growing wearable brand globally and validating the smart ring form factor as a credible alternative to the smartwatch paradigm. — Competitive Benchmark
• California's health innovation ecosystem concentrated $10B+ in venture capital in 2023, with the Bay Area capturing 35.2% of all U.S. life science funding in Q1 2025 alone, cementing the state's position as the world's preeminent longevity and digital health R&D cluster. — Competitive Benchmark
• Digital health M&A surged 61% to 195 deals in 2025, with AI companies capturing 54% of all $14.2B in sector funding, as incumbents race to acquire machine-learning diagnostics capabilities that are increasingly a prerequisite for clinical partnerships and insurance reimbursement. — Competitive Benchmark
• The longevity clinic market is bifurcating between ultra-premium concierge models (Fountain Life at $6,500–$85,000/year) and mass-market subscription entrants (Next Health at $299/month, Life Time MIORA), with the mid-market segment representing the largest untapped opportunity in California's $1.28B longevity innovation cluster. — Competitive Benchmark
• The US health & wellness market is projected to grow from $2.31 trillion in 2025 toward $10.36 trillion by 2030, representing one of the largest consumer market expansions in modern history, driven primarily by preventive healthcare adoption (11.8% CAGR) and digital health platforms. — Market Analysis
• Digital health attracted $22.3 billion in US venture capital in 2025, with AI-enabled wellness platforms capturing 54% of all capital — signaling that data-driven personalization, not product innovation, is the next competitive battleground for incumbents and startups alike. — Market Analysis
• Consumer spending patterns show a generational divide: Gen Z and Millennials (36% of US population) account for 41% of wellness spend, prioritizing mental health, personalized nutrition, and digital-first solutions, while Boomers (71.6 million by 2030) drive demand for healthy aging, preventive screenings, and supplement regimens. — Market Analysis
• The competitive landscape is fragmenting as legacy players (Abbott 12% market share, J&J's Kenvue IPO at $47.5B) face erosion from digital-native brands growing at 13.4% CAGR in D2C channels — companies that own consumer data and can personalize at scale hold an insurmountable structural advantage. — Market Analysis
• Regulatory tailwinds are accelerating: FDA approved 1,250+ AI-enabled medical devices through 2025, CMS expanded digital therapeutics reimbursement codes, and the ACA preventive care mandate protects free preventive services for 40+ million Americans — creating the policy scaffolding for industry-wide growth through 2030. — Market Analysis
• The Health & Wellness industry generates approximately 195 million annual online mentions in the United States, with a YoY growth rate of 7.9%, driven primarily by neurowellness, somatic practices, and nervous system regulation content on TikTok and Instagram. — Social Listening
• Net industry sentiment scores +72 to +85 on a scale of -100 to +100, with 82–84% of U.S. consumers rating wellness as a 'top/important' priority — though FTC enforcement actions (500+ false advertising cases filed in 2024) and misinformation spreading 70% faster than corrections represent systemic credibility risks. — Social Listening
• Neurotechnology and nervous system wellness is the fastest-growing conversation cluster, with a 19.4% CAGR in wearable neurotech, 230,000+ TikTok videos on #nervoussystemhealing, and early-adopter communities exceeding 50,000 active Reddit discussions — positioning this sub-sector as the next mainstream wellness frontier. — Social Listening
• Gen Z demonstrates a paradox of high wellness engagement (58% prioritize wellness) combined with acute trust collapse (pharma satisfaction dropped from 7 to 4 in one year among this cohort), creating a strategic imperative for science-backed, transparent communication from wellness brands targeting younger demographics. — Social Listening
• Wellness brands hold narrative dominance on TikTok and Instagram while healthcare providers maintain higher consumer trust scores (48% vs. 34% for wellness influencers), revealing a credibility gap that brands embracing clinically-grounded content and neuroscientist partnerships can exploit as a key competitive differentiator. — Social Listening
• GLP-1 drugs are expanding across five therapeutic segments—obesity, cardiovascular disease, chronic kidney disease, MASH, and addiction treatment—with the global GLP-1 market projected to reach $130.6B by 2033 at a 13.2% CAGR, but access remains severely inequitable: only 2.3% of eligible U.S. adults have received prescriptions and rural adoption lags urban areas by 37.5%. — Trend Analysis
• FDA approved semaglutide for CKD in January 2025 (24% composite kidney outcomes risk reduction via FLOW trial), and the American College of Cardiology elevated GLP-1s to first-line cardiovascular therapy in June 2025, while Phase 3 trials for alcohol use disorder are targeting completion in April 2028—creating a 2-year window for payers and providers to prepare coverage and care models for addiction indications. — Trend Analysis
• AI adoption in U.S. health systems reached 75% in 2026 (up from 59% in 2025), with digital health VC funding hitting $14.2B in 2025 (35% YoY growth)—yet a critical skills gap persists as 68% of healthcare leaders report insufficient confidence evaluating AI tools, and geographic AI adoption disparities range from 0% in some states to 49% in others. — Trend Analysis
• The PBM reform mandated by the Consolidated Appropriations Act of 2026 (100% rebate pass-through, signed February 3, 2026) and the IRA drug pricing negotiations placing semaglutide/tirzepatide in Round 2 for 2027 will reshape the economics of GLP-1 distribution—enabling direct pharma-to-patient models (e.g., LillyDirect) while eliminating the PBM spread pricing that has historically inflated access barriers. — Trend Analysis
• Three convergence vectors are redefining the industry's competitive boundaries: retail health (Amazon One Medical expanding with Nvidia/AWS AI partnerships; CVS Oak Street scaling to 300+ sites), health-fintech integration ($147B HSA market enabling pre-tax GLP-1 payments for 7M+ newly eligible Americans), and the fitness industry pivoting to medically supervised GLP-1 programs as gym membership value propositions fundamentally shift. — Trend Analysis

May 2026

• The U.S. menopause and perimenopause consumer segment — encompassing an estimated 64 million women — is the fastest-growing female health cohort with a 6.7% CAGR, yet 87% of symptomatic women do not seek medical care, representing a massive addressable gap for FemTech and wellness solutions. — Audience Profiles
• McKinsey's 'Maximalist Optimizer' female wellness consumer (25% of the market) accounts for over 40% of all wellness spending, averaging $100+ per month across supplements, devices, and digital health services — making this high-LTV segment the primary acquisition target for premium health brands. — Audience Profiles
• The women's digital health market is projected to grow at a 20.56% CAGR from $3.22 billion (2024) to $25.17 billion by 2035, driven by reproductive health apps, menopause management platforms, and FemTech wearables — with mobile-first Gen Z and Millennial consumers at the vanguard. — Audience Profiles
• Clinical dismissal remains the #1 pain point: 93% of women report being dismissed when seeking medical help for hormonal health conditions, while only 8.8% of NIH spending (FY2013–2023) targeted women's health — creating a trust vacuum that community-led digital brands and telehealth platforms are uniquely positioned to fill. — Audience Profiles
• Gen X women, who hold $15.2 trillion in global spending power and are the primary drivers of the $5.56 billion U.S. menopause supplement market, are chronically undermarketed by the health industry — yet represent the single highest-ROI audience for brands investing in perimenopause and menopause solutions. — Audience Profiles
• Apple Watch holds approximately 55% of the U.S. smartwatch market and 28% of the overall wearable device market, supported by an ecosystem lock-in effect that drives 92% retention rates among iPhone users. — Competitive Benchmark
• The CGM segment is controlled by a near-duopoly: Abbott FreeStyle Libre commands 56.7% market share while Dexcom holds 35.2%, together generating combined revenues exceeding $6 billion in 2025 and expanding rapidly through OTC channels (Dexcom Stelo, Abbott Lingo). — Competitive Benchmark
• Subscription-first wearable models are proving highly scalable: Whoop reached $1.1 billion in annualized revenue (103% YoY growth) and Oura Ring surpassed $900 million, with both companies achieving retention rates above 80% through AI-driven personalization. — Competitive Benchmark
• AI health coaching is transitioning from differentiator to table stakes: Samsung integrated Gemini AI into Galaxy Watch 8 series (2025), Fitbit launched an AI concierge, Oura acquired Galen AI for health data unification, and Apple plans ChatGPT integration in watchOS 26 — signaling a full-industry convergence. — Competitive Benchmark
• Non-invasive continuous glucose monitoring is the highest-stakes innovation race, with Apple and Samsung both investing in proof-of-concept research; commercial deployment is projected between 2027 and 2030, which would collapse the boundary between consumer wearables and clinical CGM devices. — Competitive Benchmark
• GLP-1 medications represent a generational growth opportunity in pharmaceutical markets, with expansion driven by both disease prevalence (42% obesity, 15.8% diabetes) and regulatory validation of new therapeutic applications beyond weight management. — Market Analysis
• GLP-1 market is transforming from single-disease therapeutic (diabetes) to multi-indication platform, driven by FDA approvals in cardiovascular and renal protection; obesity indication now represents 45% of TAM and growing at 2.3x the diabetes rate. — Market Analysis
• GLP-1 growth is driven by massive disease prevalence (130M+ obese Americans) and FDA regulatory validation of multiple indications, but access constraints (insurance coverage gaps, unaffordable pricing, prior authorization) limit addressable market to 21% of eligible population—policy and payer alignment are critical to growth realization. — Market Analysis
• Eli Lilly has achieved decisive market leadership through superior clinical differentiation of dual GLP-1/GIP mechanism (tirzepatide), achieving 60.5% US market share; Novo faces declining market share despite oral formulation launches, signaling that efficacy advantages outweigh delivery innovation in prescriber decision-making. — Market Analysis
• GLP-1 pricing is characterized by extreme list-to-net divergence (42% realization after rebates), driving disintermediation through DTC platforms and compounding; manufacturers must navigate margin compression from Medicare price negotiation while maintaining rebate-dependent PBM relationships. — Market Analysis
• The sober-curious movement is reshaping social wellness conversations: 49% of Americans reported reducing alcohol consumption in 2025, with #SoberCurious generating 500M+ TikTok views and Dry January participation rising 36% year-over-year to reach 30% of the US adult population. — Social Listening
• TikTok has become the dominant engagement platform for Health & Wellness content, achieving an 8.1% category engagement rate — 17x higher than Instagram's platform average — while Reddit's 700+ health communities show 75% of users trusting health information sourced there more than any other platform. — Social Listening
• Wellness sentiment is strongly positive overall (84% of US consumers rate wellness as a top priority), but negative narratives around misinformation, influencer credential gaps, and wellness commercialization are rising, with only 4-5% of social health content produced by credentialed experts. — Social Listening
• Generational polarization is accelerating: Gen Z shows 65% intent to reduce or eliminate alcohol, and 41% express interest in sober-bar concepts, while the wellness community-building narrative is drawing Millennials who allocate 11% of monthly income to wellness — collectively driving 41% of the $1.3 trillion US wellness market. — Social Listening
• Connection-driven wellness communities and alcohol-free social infrastructure represent the highest-growth narrative whitespace in the industry, with alcohol-free venue counts growing 478% in recent years and online peer support communities on Reddit and Discord posting double-digit monthly growth in membership. — Social Listening
• The U.S. neurowellness market (vagus nerve stimulation, EEG neurofeedback, biofeedback wearables) is expanding rapidly, with vagus nerve stimulation wearables alone valued at $1.2 billion in 2025 and projected to reach $2.1 billion by 2030, signaling a major category shift from passive wellness to active nervous system regulation. — Trend Analysis
• AI-powered mental health tools are crossing the clinical adoption threshold: 25% of therapists now actively integrate AI tools, 30% of U.S. adults have used AI for mental health support, and the digital mental health market is on track to grow from $7.46 billion (2025) to $47.13 billion (2035) at a 20.25% CAGR. — Trend Analysis
• Venture capital investment in neurotechnology surged 62% year-over-year in 2025 to $2.1 billion, with Q1 2026 neurotechnology funding reaching $976 million — a 577% increase year-over-year — indicating exceptional investor conviction in AI-nervous system regulation convergence. — Trend Analysis
• The mental health workforce shortage is a critical structural constraint: 40% of the U.S. population lives in mental health professional shortage areas, with an 88,000+ counselor deficit projected, creating a structural demand gap that technology-augmented delivery models are uniquely positioned to address. — Trend Analysis
• Regulatory clarity is emerging as the key inflection point: the FDA has authorized 1,250+ AI/ML-based medical devices (32% YoY growth), and CMS expanded digital therapeutics reimbursement in 2025 — but 79% of neurotechnology products still lack FDA clearance, creating first-mover advantage for companies that pursue clinical validation proactively. — Trend Analysis

April 2026

• Gen Z consumers (ages 18–26) represent the fastest-growing wellness spending cohort in the U.S., with the Gen Z mental health market valued at $33.44B in 2025 and projected to reach $49.7B by 2030 (8.25% CAGR). — Audience Profiles
• 70% of Gen Z prefer virtual therapy over in-person treatment, and mental health app downloads have grown 30%+ annually since 2021, displacing traditional therapy as the first point of contact for mental health support. — Audience Profiles
• Run club participation surged 59% globally in 2025, with Gen Z 4x more likely to form new social connections through fitness communities than bars—signaling a structural rejection of alcohol-centric social formats. — Audience Profiles
• The Pacific Northwest wellness market shows a 6.9% regional CAGR (1.4–2.1% above the national average), driven by high-income tech worker concentrations in Seattle/Bellevue and a deeply embedded outdoor wellness culture. — Audience Profiles
• Mental health app 30-day retention stands at just 3.3%, revealing a critical engagement gap: platforms that integrate community features and personalized AI achieve 87% retention versus 60% for standard onboarding flows. — Audience Profiles
• CVS Health leads the integrated wellness market with $402 billion in FY2025 revenue and a 15.8% prescription market share, underpinned by its Aetna-Caremark-Oak Street Health payvider ecosystem spanning over 9,000 pharmacy and 1,500 HealthHUB locations. — Competitive Benchmark
• Walgreens Boots Alliance recorded $8.6 billion in net losses in FY2024 after its $14.2 billion healthcare write-down on the failed VillageMD expansion, forcing the closure of 1,200 stores and a pivot away from clinic-based care toward virtual care partnerships. — Competitive Benchmark
• Amazon Pharmacy, despite holding less than 0.3% of the U.S. pharmacy market by revenue (~$1.8 billion), is the fastest-growing player with triple-digit Q1 2025 growth and plans to reach 45% U.S. same-day delivery coverage by end-2025, posing the most credible long-term disruption threat. — Competitive Benchmark
• Digital-first disruptors captured an estimated $7 billion in venture funding in 2024, with Hims & Hers achieving $2.3 billion in projected 2025 revenue and first-year profitability, primarily driven by GLP-1 weight-loss and mental health subscription services that compete directly with retail pharmacy health ecosystems. — Competitive Benchmark
• Customer satisfaction data from J.D. Power shows chain drugstores (CVS: 641/1,000; Walgreens: 634/1,000) significantly trail supermarket pharmacies (715/1,000) and mail-order providers, with Amazon's integrated Prime-Pharmacy-One Medical model creating the strongest satisfaction flywheel among digital players. — Competitive Benchmark
• Market bifurcation by delivery model: Digital mental health growing at 20.25% CAGR vs. traditional corporate wellness at 4.64% CAGR, indicating fundamental consumer and employer preference shift toward technology-enabled care and provider shortage response. — Market Analysis
• Burnout epidemic creating powerful employer demand: 44% of surveyed U.S. employees report burnout affecting 1 in 3 workers, with turnover costs reaching USD 322 billion annually—creating USD 4:1 ROI incentive for employer mental health investment and strategic talent retention lever. — Market Analysis
• Severe provider shortage driving digital adoption: 40% of U.S. population (122M Americans) in Mental Health Professional Shortage Areas with 4.5:1 demand-supply gap guarantees digital/AI-augmented care models will capture disproportionate market share and valuations beyond traditional therapy. — Market Analysis
• Mid-market penetration gap represents USD 30B+ opportunity: Large enterprises (67.5% of corporate wellness spend) have achieved 82% EAP adoption and digital integration, while mid-market employers show significant adoption lag with 25-33% of employees unaware of available benefits. — Market Analysis
• Regulatory momentum supporting market expansion: CMS digital therapeutics reimbursement (effective Jan 2025), DEA/Medicare telehealth extensions (through 2026-2027), and state-level mental health mandates create favorable policy environment—offsetting May 2025 MHPAEA enforcement pause uncertainty. — Market Analysis
• Medical cost trends at 8.5% in 2026 have made healthcare affordability the #1 domestic concern for Americans, surpassing the economy by 10 points in March 2026 Gallup polling, generating historically high negative conversation volume across all social platforms. — Social Listening
• Reddit has emerged as the dominant platform for authentic health advocacy discourse, registering 48% year-over-year growth in healthcare conversations and 1,328% SEO visibility growth, making it the highest-trust source for peer health information among adults under 45. — Social Listening
• Consumer trust in the Health & Wellness industry has structurally collapsed: 75%+ of Americans believe providers and insurers prioritize profit over patients, health insurer value-for-money scores turned negative for Millennials and Gen X, and pharmacy/pharma trust declined globally despite the sector's centrality to public health. — Social Listening
• The GLP-1/Ozempic narrative is the fastest-growing conversation thread in the industry — projected to reach 25 million U.S. users by 2030 and driving a simultaneous surge in telehealth adoption, generic drug access advocacy, and metabolic health content that brands have not yet fully leveraged. — Social Listening
• Hospital price transparency compliance stands at only 21.1% nationally despite a 2025 White House executive order escalating enforcement, creating a significant narrative whitespace for industry participants willing to proactively champion transparent pricing as a patient empowerment value. — Social Listening
• The U.S. health & wellness market surpassed $2.3 trillion in 2025, growing at a 5.4% CAGR through 2034, with microbiome products representing the fastest-growing segment at a 30.97% CAGR—signaling structural demand for gut-health and preventive nutrition solutions. — Trend Analysis
• Consumer behavior has shifted decisively toward preventive health: Gen Z and Millennials represent 36% of the U.S. population but 41% of wellness spending, with 94% of Americans using dietary supplements and functional food purchases growing from $260B (2026) toward $444B by 2036. — Trend Analysis
• Food-as-medicine is transitioning from niche concept to healthcare policy: the Rockefeller Foundation estimates a $45B economic opportunity from Medically Tailored Meals, the Food Is Medicine Coalition released the first-ever national reimbursement blueprint in March 2026, and 32+ states have enacted food-as-medicine legislation. — Trend Analysis
• FDA regulatory modernization is the single most consequential near-term risk factor, with 2026 Human Foods Program priorities targeting dietary supplement oversight, GRAS reform, and NDI notifications—creating compliance urgency for thousands of supplement products currently lacking formal authorization. — Trend Analysis
• Digital health investment in preventive care totaled $10.1 billion in the U.S. in 2025, with D2C supplement e-commerce growing at a 9.6% CAGR and TikTok Shop capturing nearly 20% of social commerce in 2025, fundamentally redistributing channel power away from traditional retail. — Trend Analysis
• The US wellness market reached $2 trillion in 2025 — 32% of the global wellness economy — with per capita spending of $6,293 annually, growing at 7.9% per year, driven by structural prioritization of health even amid broader consumer spending restraint. — Audience Profiles
• Women's health is the fastest-growing consumer segment, with 50 million women in or approaching menopause, a menopause management market valued at $5.56 billion, and an emerging ovarian aging intervention category poised to redefine female longevity spending through 2030. — Audience Profiles
• Gen Z and Millennials jointly drive 41% of US wellness spend — exceeding their 36% population share — with divergent priorities: Gen Z leads community fitness and social wellness formats while Millennials concentrate on personalized nutrition, mental health apps, and stress management solutions. — Audience Profiles
• The employer-sponsored wellness benefits market totals $24.5 billion in 2026 and is projected to reach $39.27 billion by 2035, with 85% of large employers offering programs; mental health benefits are the top investment priority (86% of HR leaders increasing allocation) followed by weight management (75%). — Audience Profiles
• Digital health adoption has crossed mainstream thresholds — 40%+ of US consumers use health apps, 49% engage AI wellness coaching daily, and social media influences over 72% of wellness purchasing decisions — yet 95%+ of viral health content lacks expert credentials, creating a trust arbitrage opportunity for credentialed wellness brands. — Audience Profiles
• The US digital health and wellness market is bifurcating rapidly: Q1 2026 saw 60% of $5.34 billion in funding concentrated in just 12 mega-deals, signaling that capital is consolidating around vertically integrated platforms with proprietary data and contracted revenue streams. — Competitive Benchmark
• GLP-1 medications are the most significant competitive disruptor in the sector, driving a $101.4 billion market opportunity by 2026 and forcing incumbents across wearables, telehealth, nutrition, and fitness to launch companion digital programs or risk obsolescence. — Competitive Benchmark
• Wearables leadership remains concentrated among three players — Apple (23% global smartwatch share), Oura Ring ($875M Series E at $10.9B valuation), and Garmin (33% YoY fitness revenue growth) — while telehealth is led by Teladoc (~25% share) with the top 5 controlling approximately 60% of sector revenue. — Competitive Benchmark
• The employer-sponsored benefits channel (B2B2C) is emerging as the dominant go-to-market strategy, with 64% of employers adopting Lifestyle Spending Accounts and mental health EAP providers like Lyra Health and Spring Health growing through enterprise contracts rather than direct-to-consumer acquisition. — Competitive Benchmark
• AI-native disruptors — including mental health chatbots (Woebot, Wysa, Youper), precision nutrition startups, and continuous glucose monitoring platforms (Levels Health, Nutrisense) — are capturing early funding rounds and challenging incumbents on personalization depth and cost-to-serve, with the AI mental health market projected to grow from $1.71B (2025) to $9.12B by 2033. — Competitive Benchmark
• The US wellness market reached $2.31 trillion in 2025 and is forecast to grow to $3.70 trillion by 2034, with GLP-1 drugs alone generating $76 billion in global sales in 2025 — projected to reach $162 billion by 2031 at a 17.5% CAGR. — Market Analysis
• The CMS ACCESS Model launching July 5, 2026 establishes the first outcome-aligned reimbursement framework for technology-supported chronic care in Original Medicare, representing a structural catalyst for digital health monetization serving 40M+ beneficiaries. — Market Analysis
• Group healthcare costs are projected to rise 8.5% in 2026, driven by GLP-1 drug utilization increases of 73.1% and specialty drug trend acceleration, creating simultaneous pressure on payers and strategic opportunity for cost-reduction-focused wellness platforms. — Market Analysis
• Digital health venture funding surged to $14.2 billion in 2025 — the highest since 2022 — with AI-enabled startups capturing 62% of deployed capital and Q1 2026 already reaching $4 billion across 110 deals at an average deal size of $36.7 million. — Market Analysis
• Functional foods and dietary supplements are forecast at 7.5–8.6% CAGR through 2030, with GLP-1 users projected to represent 35% of US food and beverage sales by 2030, reshaping product formulation priorities across the nutrition segment. — Market Analysis
• The US Health & Wellness industry generates approximately 46.8 million annual online mentions with a moderately positive net sentiment score of +38, though GLP-1 drug conversations skew negative (-40 to -50 sentiment range) due to side effect disclosures and access equity debates on Reddit and X/Twitter. — Social Listening
• TikTok is the dominant engagement platform for wellness content, generating 3.7–4.9% average engagement rates versus Instagram's 0.48–0.98%, with GLP-1 testimonial content generating 70 million views per 100 videos and run club community content posting 59% year-over-year growth. — Social Listening
• The 'soft wellness' counter-movement — rejecting biohacker optimization culture in favor of rest, somatic healing, and nervous system regulation — is the fastest-growing sentiment cluster among Gen Z, with 71% of Gen Z reporting the lowest workplace health scores and actively embracing anti-hustle narratives on TikTok. — Social Listening
• Regional GLP-1 prescription disparities reveal a 5.7x gap between the highest-prescribing state (Kentucky, 21 per 1,000 patients) and the lowest (Rhode Island, 3.7 per 1,000), with access equity sentiment driving negative conversations concentrated in Southern and rural markets. — Social Listening
• Longevity content is the highest-growth conversation cluster, with the longevity biotech sector attracting 40% more institutional investment year-over-year and biological age testing transitioning from niche biohacker interest to mainstream consumer interest — with the longevity wellness market projected to reach $610 billion by 2025. — Social Listening
• The US wellness economy reached $2.1 trillion in 2024, growing at 7.9% CAGR, with AI-powered wearables and preventive health technologies driving the highest-growth sub-segments; the global market is projected to reach $9.8 trillion by 2029. — Trend Analysis
• Neurowellness is the #1 Global Wellness Summit trend for 2026: 57 million US adults already use brain-wellness tools, the consumer neurotech market is growing at 21.7% CAGR, and EEG wearable startups raised over $35 million in single rounds in 2025–2026. — Trend Analysis
• Digital health VC investment totaled $14.2 billion in 2025 (54% captured by AI-enabled companies), with Q1 2026 adding $5.34 billion — the highest single-quarter total on record — signaling accelerating capital confidence in AI-driven health platforms. — Trend Analysis
• The CMS ACCESS Model, launching July 5, 2026, creates a 10-year Medicare reimbursement framework for AI-enabled chronic disease management via wearables and telehealth, covering two-thirds of Medicare beneficiaries and validating the preventive health business model at scale. — Trend Analysis
• A structural healthcare workforce gap of 3.2 million workers by 2026 is accelerating AI augmentation adoption, while the global health coaching industry grew to $20+ billion with 10.2% CAGR — making AI-augmented coaching the highest-velocity workforce segment in the industry. — Trend Analysis

Where do these figures come from?

Each figure is taken verbatim from a Kenmei Drive intelligence report for health & wellness in the United States, and links back to it. Reports are produced with AI-assisted research and reviewed by analysts before publication, drawing on publicly available market information. See our methodology for the full process and its limitations.

Cited organizations: Digital Information World · Web Tonic · Dash Social · Business of Apps · Grand View Research · JD Power · Toward Healthcare · Business Research Insights · CMS · McKinsey · Urban Institute · Precedence Research · SourceReady · GM Insights · Mordor Intelligence · Open PR · IBISWorld · Galen Growth · GM Insights & Fortune Business Insights · Sacra

How often is this updated?

Every month. Kenmei Drive publishes five new health & wellness reports for the United States each month, and this page picks up their figures automatically.

All health & wellness reports · Health & Wellness intelligence

Key statistics for other industries

• Retail & Wholesale Commerce statistics
• Professional Services statistics
• Education & Training statistics
• Tourism & Hospitality statistics
• Construction & Real Estate statistics
• Light Manufacturing & Workshops statistics
• Agribusiness & Food statistics
• Technology & IT statistics
• Transportation & Logistics statistics
• Banking & Financial Services statistics